-
June 18, 2013
As per Reuters, several pharmaceutical companies have shown an interest in acquiring ViroPharma given the company's ...
-
June 18, 2013
AstraZeneca entered into an agreement with NGM Biopharmaceuticals, Inc. to develop candidates for type II diabetes ...
-
June 17, 2013
Namenda XR is a once-daily extended-release version of the company's immediate release formulation of Namenda.
-
June 17, 2013
XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory ...
-
June 13, 2013
UCB recently presented new data on its lupus candidate, epratuzumab, from an open-label extension study of the ...
-
June 13, 2013
The FDA's advisory panel will review Salix' supplemental new drug application for Relistor for opioid-induced ...
-
June 12, 2013
ViroPharma recently received "orphan drug designation" in the EU for its pipeline candidate, maribavir, ...
-
June 12, 2013
Shares of Questcor received a major boost when the company announced the acquisition of development and ...
-
June 11, 2013
AstraZeneca entered into a definitive agreement to purchase US based privately-held company, Pearl Therapeutics
-
June 10, 2013
Gentium S.p.A. announced that it is seeking a re-examination of the negative opinion issued on defibrotide by the ...
-
June 10, 2013
Novartis (NVS) recently released encouraging data on its pipeline candidate, LDK378, from a phase I study.
-
June 07, 2013
Novartis recently announced positive results on Afinitor, from a phase III trial, BOLERO-3 (Breast cancer trials of ...
-
June 07, 2013
BioLineRx recently announced that it has enrolled the first patient in a phase II study of BL-8040, for the ...
-
February 12, 2013
UCB (UCBJF) and Amgen Inc. (AMGN) recently announced their decision to discontinue a phase III program being ...
-
February 08, 2013
Avanir Pharmaceuticals, Inc. (AVNR) reported first quarter fiscal 2013 net loss per share of 9 cents, wider than the ...
-
February 06, 2013
ArQule, Inc. (ARQL) and partner Daiichi Sankyo recently announced that former has enrolled the first patient for the ...
-
February 06, 2013
Good news flowed in at UCB (UCBJF) from Europe when the European Union (EU) approved Vimpat (lacosamide) as a single ...
-
February 04, 2013
Valeant Pharmaceuticals International, Inc. (VRX) recently closed the acquisition of Russia-based Natur Produkt ...
-
January 31, 2013
Auxilium Pharmaceuticals, Inc. (AUXL) recently announced the initiation of a patent infringement lawsuit against ...
-
January 30, 2013
Anacor Pharmaceuticals, Inc. (ANAC) recently announced positive preliminary results on tavaborole (AN2690) from ...
